Successful Treatment of a Miliary Metastatic NSCLC Patient With Activating EGFR Exon 20 Insertion Mutation with Response to Poziotinib

被引：6
作者：
Yang, Juyin [1 ]
Yang, Jian [2 ]
Ban, Shao [3 ]
Li, Xinmin [2 ]
Chen, Xingde [4 ]
Yang, Jihua [4 ]
Qian, Jun [2 ]
机构：
[1] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Pharm, Dehong, Yunnan, Peoples R China
[2] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Cardiothorac Surg, 13 Yonghan St, Dehong 678400, Yunnan, Peoples R China
[3] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Cardiovasc Med, Dehong, Yunnan, Peoples R China
[4] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Pathol, Dehong, Yunnan, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 09期
关键词：
D O I：
10.1016/j.jtho.2019.04.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E198 / E200
页数：3
相关论文
共 50 条
  • [41] Poziotinib activity and durability of responses in previously treated EGFR exon 20 NSCLC patients - a Phase 2 study
    Le, Xiuning
    Goldman, Jonathan
    Clarke, Jeffrey
    Techekmedyian, Nishan
    Piotrowska, Zofia
    Chu, David
    Bhat, Gajanan
    Lebel, Francois
    Socinski, Mark
    CANCER RESEARCH, 2020, 80 (16)
  • [42] Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients.
    Le, Xiuning
    Goldman, Jonathan Wade
    Clarke, Jeffrey Melson
    Tchekmedyian, Nishan
    Piotrowska, Zofia
    Chu, David
    Bhat, Gajanan
    Lebel, Francois M.
    Socinski, Mark A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Resistance mechanisms to mobocertinib in treating NSCLC with EGFR exon 20 insertion mutations
    Le, Xiuning
    Nilsson, Monique
    Chatterjee, Sampurna
    Su, Zhenqiang
    He, Junqin
    Udagawa, Hibiki
    Yu, Xiaoxing
    Poteete, Alissa
    Huang, Qian
    Heymach, John V.
    Vincent, Sylvie
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [44] Sunvozertinib for the treatment of NSCLC with EGFR Exon20 insertion mutations: The first pivotal study results
    Wang, Mengzhao
    Fan, Yun
    Sun, Meili
    Wang, Yongsheng
    Zhao, Yanqiu
    Jin, Bo
    Hu, Ying
    Han, Zhigang
    Song, Xia
    Liu, Anwen
    Tang, Kejing
    Ding Cuimin
    Liang, Li
    Wu, Lin
    Gao, Junzhen
    Wang, Jianghong
    Cheng, Ying
    Zhou, Jianying
    He, Yong
    Zheng, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Sunvozertinib as first-line treatment in NSCLC patients with EGFR Exon20 insertion mutations
    Yang, J. C-H.
    Wang, M.
    Chiu, C-H.
    Hsu, P-C.
    Mitchell, P.
    Chang, C. L.
    Kim, T. M.
    John, T.
    Greillier, L.
    Bazhenova, L.
    Carcereny, E.
    Spira, A. I.
    Shim, B.
    Lee, K. H.
    Cobo Dols, M.
    Ghiringhelli, F.
    Yip, C. W.
    Xiong, J.
    Janne, P. A.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2023, 34
  • [46] Efficacy and safety of sunvozertinib in treatment naive NSCLC patients with EGFR exon20 insertion mutations
    Xu, Yan
    Yang, James Chih-Hsin
    Chiu, Chao-Hua
    Hsu, Ping-Chih
    Mitchell, Paul
    Chang, Chia Lun
    John, Tom
    Bazhenova, Lyudmila
    Kim, Tae Min
    Yip, Ching Wan
    Wang, Mengzhao
    Janne, Pasi A.
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Durable Response of Low-Dose Afatinib plus Cetuximab in an Adenocarcinoma Patient with a Novel EGFR Exon 20 Insertion Mutation
    Fang, Wenfeng
    Huang, Yihua
    Gan, Jiadi
    Shao, Yang W.
    Zhang, Li
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : E220 - E221
  • [48] Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib A case report
    Cai, Yangyang
    Wang, Xu
    Guo, Ye
    Sun, Chao
    Xu, Yinghui
    Qiu, Shi
    Ma, Kewei
    MEDICINE, 2019, 98 (01)
  • [49] Successful Treatment of EGFR Exon 19 Deletion with TP53 and ERBB2 20ins Mutation in Stage IVB NSCLC Patient with Aumolertinib
    Liu, C.
    Zhu, H.
    Nuerlan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S446 - S447
  • [50] A Case of a Patient Harboring an EGFR Insertion of Exon 20 and Long Lasting Clinical Response to Afatinib
    Lorandi, V.
    Macedo, G.
    Goncalves, V. K.
    Piccoli, R.
    Stefani, S.
    Gelatti, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2137 - S2138
12345